The effects of MK-185 on thyroid function.
D000081:Acetamides / Q000008:administration & dosage / Q000494:pharmacology; D000284:Administration, Oral; D000368:Aged; D000924:Anticholesteremic Agents / Q000494:pharmacology; D001796:Blood Protein Disorders; D002994:Clofibrate / Q000494:pharmacology; D005260:Female; D005461:Fluorine / Q000008:administration & dosage / Q000494:pharmacology; D006016:Glycolates / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007456:Iodine Isotopes; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011422:Propionates / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D013954:Thyroglobulin / Q000032:analysis; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000187:drug effects*; D013974:Thyroxine / Q000097:blood; D013997:Time Factors
D000081:Acetamides; D000924:Anticholesteremic Agents; D006016:Glycolates; D007456:Iodine Isotopes; D008074:Lipoproteins; D010919:Placebos; D011422:Propionates; D005461:Fluorine; D013954:Thyroglobulin; D002994:Clofibrate; D013974:Thyroxine